Dipartimento di Neuroscienze, Ospedale Misericordia, Via Senese, 171, 58100, Grosseto, Italy.
Neurol Sci. 2012 Jun;33(3):585-93. doi: 10.1007/s10072-011-0807-x. Epub 2011 Nov 3.
Using data from the PRIAMO study, we investigated non-motor symptoms (NMS) versus frontal lobe dysfunction in patients with idiopathic Parkinson disease (PD); 808 patients with PD and 118 with atypical parkinsonisms (AP) were consecutively enrolled at 55 Centers in Italy. Twelve categories of NMS were investigated. Cognitive impairment was defined as a Mini-Mental Status Evaluation score ≤ 23.8 and frontal lobe dysfunction as a Frontal Assessment Battery (FAB) score ≤ 3.48. Multivariable logistic regression was used to identify predictor of frontal lobe dysfunction in 524 PD patients, and a generalized linear model was used for each of the six FAB items. Not only the total FAB scores but also the single FAB items were lower in AP versus PD (p ≤ 0.005). Age (OR = 1.05), cognitive impairment (OR = 9.54), lack of cardiovascular symptoms (OR = 3.25), attention or memory problems (OR = 0.59) and treatment with L: -DOPA (OR = 5.58) were predictors of frontal lobe dysfunction. MMSE was negatively associated with all FAB items (β ≤ -0.16) and age with all FAB items but prehension behavior (β ≤ -0.01). Previous use of L: -DOPA was negatively associated with verbal fluency (β = -0.32) possibly acting as surrogate marker of disease duration. Cognitive impairment is a predictor of frontal lobe dysfunction. Among NMS, lack of attention or memory problems were negatively associated with frontal impairment. Further studies are nonetheless needed to better identify the predictors of frontal impairment in PD patients.
使用 PRIAMO 研究的数据,我们调查了特发性帕金森病 (PD) 患者的非运动症状 (NMS) 与额叶功能障碍;连续纳入意大利 55 个中心的 808 例 PD 患者和 118 例非典型帕金森病 (AP) 患者。研究了 12 类 NMS。认知障碍定义为简易精神状态评估评分≤23.8,额叶功能障碍定义为额叶评估量表 (FAB) 评分≤3.48。使用多变量逻辑回归分析 524 例 PD 患者中额叶功能障碍的预测因素,并对每个 FAB 项目进行广义线性模型分析。与 PD 相比,AP 的总 FAB 评分和各单项 FAB 评分均较低 (p≤0.005)。年龄 (OR=1.05)、认知障碍 (OR=9.54)、缺乏心血管症状 (OR=3.25)、注意力或记忆问题 (OR=0.59) 和左旋多巴治疗 (OR=5.58) 是额叶功能障碍的预测因素。MMSE 与所有 FAB 项目呈负相关 (β≤-0.16),年龄与所有 FAB 项目但抓握行为呈负相关 (β≤-0.01)。左旋多巴的既往使用与言语流畅性呈负相关 (β=-0.32),可能作为疾病持续时间的替代标志物。认知障碍是额叶功能障碍的预测因素。在 NMS 中,缺乏注意力或记忆问题与额叶损伤呈负相关。然而,仍需要进一步研究以更好地确定 PD 患者额叶损伤的预测因素。